Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave J P, Zirngibl H, Offermanns S, Gachet C
Department of Molecular Oncology, General Surgery, Witten/Herdecke University, Arrenbergerstrasse 20, 42117 Wuppertal, Germany.
Blood. 2001 Jun 15;97(12):3829-35. doi: 10.1182/blood.v97.12.3829.
Collagen-induced platelet aggregation is a complex process and involves synergistic action of integrins, immunoglobulin (Ig)-like receptors, G-protein-coupled receptors and their ligands, most importantly collagen itself, thromboxane A(2) (TXA(2)), and adenosine diphosphate (ADP). The precise role of each of these receptor systems in the overall processes of activation and aggregation, however, is still poorly defined. Among the collagen receptors expressed on platelets, glycoprotein (GP) VI has been identified to play a crucial role in collagen-induced activation. GPVI is associated with the FcRgamma chain, which serves as the signal transducing unit of the receptor complex. It is well known that clustering of GPVI by highly specific agonists results in platelet activation and irreversible aggregation, but it is unclear whether collagen has the same effect on the receptor. This study shows that platelets from Galphaq-deficient mice, despite their severely impaired response to collagen, normally aggregate on clustering of GPVI, suggesting this not to be the principal mechanism by which collagen activates platelets. On the other hand, dimerization of GPVI by a monoclonal antibody (JAQ1), which by itself did not induce aggregation, provided a sufficient stimulus to potentiate platelet responses to Gi-coupled, but not Gq-coupled, agonists. The combination of JAQ1 and adrenaline or ADP, but not serotonin, resulted in alpha(IIb)beta(3)-dependent aggregation that occurred without intracellular calcium mobilization and shape change in the absence of Galphaq or the P2Y(1) receptor. Together, these results provide evidence for a cross-talk between (dimerized) GPVI and Gi-coupled receptors during collagen-induced platelet aggregation. (Blood. 2001;97:3829-3835)
胶原诱导的血小板聚集是一个复杂的过程,涉及整合素、免疫球蛋白(Ig)样受体、G蛋白偶联受体及其配体的协同作用,其中最重要的是胶原本身、血栓素A2(TXA2)和二磷酸腺苷(ADP)。然而,这些受体系统在激活和聚集的整体过程中各自的确切作用仍不清楚。在血小板上表达的胶原受体中,糖蛋白(GP)VI已被确定在胶原诱导的激活中起关键作用。GPVI与FcRγ链相关联,后者作为受体复合物的信号转导单位。众所周知,高度特异性激动剂使GPVI聚集会导致血小板激活和不可逆聚集,但尚不清楚胶原对该受体是否有相同作用。本研究表明,来自Gαq缺陷小鼠的血小板,尽管它们对胶原的反应严重受损,但在GPVI聚集时通常会聚集,这表明这不是胶原激活血小板的主要机制。另一方面,单克隆抗体(JAQ1)使GPVI二聚化,其本身不会诱导聚集,但能提供足够的刺激来增强血小板对Gi偶联激动剂而非Gq偶联激动剂的反应。JAQ1与肾上腺素或ADP(而非血清素)联合使用,会导致α(IIb)β(3)依赖性聚集,这种聚集在没有Gαq或P2Y(1)受体的情况下,在没有细胞内钙动员和形状改变的情况下发生。总之,这些结果为胶原诱导的血小板聚集中(二聚化的)GPVI与Gi偶联受体之间的相互作用提供了证据。(《血液》。2001年;97:3829 - 3835)